Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot and Feasibility Study of [68Ga]Ga-THP-PDL1-3 PET/CT in Solid Tumors
NCT06383598Completed
- Start
- Apr 2024
- Primary completion
- May 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of [68Ga]Ga-THP-PDL1-3 in solid tumor. Primary endpoint: Safety and Feasibility at 14 days. Started Apr 2024; status: completed.
02
Drugs
[68Ga]Ga-THP-PDL1-3
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06383598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06383598.